ATS 2018 International Conference - Mobile

Mark Labadia

PhD

Boehringer Ingelheim Pharmaceuticals, Inc.

Session(s)

The Potential for RORgamma Antagonists to Treat A Sub-Population of Severe Asthma: A Trans...
Wednesday, May 23 9:15 AM - 9:30 AM